Skip to main content
Loading

El Capitan Biosciences

October 15, 2024
California Room
Gastrointestinal
El Capitan Biosciences
At El Capitan Biosciences (ECB), our mission is to harness advanced machine learning algorithms to discover novel clinically-significant biomarkers in stool samples to zero-out the incident of CRC. By addressing the critical barriers that deter regular screening, such as accessibility, cost, and convenience, our innovative approach seeks to enhance early disease detection when follow-up treatment is both clinically and cost-effective.
Speakers
Xiao Yang, CEO - El Capitan Biosciences

DOUBLE HELIX SPONSOR

HELIX SPONSOR

PREMIER SPONSOR

CONFERENCE SPONSORS